Results 41 to 50 of about 269,068 (254)
Efficacy of apheresis platelet transfusion in 310 patients with haematological diseases
Objective To observe the effect of platelet transfusion in inpatients with haematological diseases, analyze the possible causes of platelet transfusion refractoriness (PTR), in order to further improve the efficacy of platelet transfusion.
Shisong YOU +5 more
doaj +1 more source
Objectives The aim of this study was to investigate whether ROTEM platelet can provide additional information to the traditional ROTEM analysis to guide treatment with platelet transfusions in cardiac surgery and to identify factors triggering platelet ...
Agneta Wikman +11 more
core +1 more source
This study demonstrates that a preoperative FIB‐4 index ≥ 5.0 independently predicts severe complications and endogenous organ failure (EOF) following hepatectomy for hepatocellular carcinoma. By capturing structural liver fragility and systemic vulnerability, the FIB‐4 index enhances surgical risk stratification beyond traditional functional markers ...
Masanori Nakamura +9 more
wiley +1 more source
Background A response to platelet transfusion is assessed by post transfusion platelet increment and failure to reach a desired increment is termed platelet refractoriness, which is best measured by the corrected count increment (CCI) which takes into ...
Luhulla, Koga Malunguja +4 more
core +1 more source
ABSTRACT Current treatments for immune thrombocytopenia (ITP) and warm autoimmune hemolytic anemia (wAIHA), rare autoimmune diseases in which autoreactive B cells play a major role, can lead to high response rates; however, for many patients these responses are not durable or maintained after treatment discontinuation.
Matthieu Mahévas +4 more
wiley +1 more source
Background and Objectives: Transfusion support for immune-mediated platelet refractoriness (PR) is clinically challenging, technically laborious and costly.
Sousa, L C D M +5 more
core +2 more sources
[Objective] To evaluate the performance of platelet efficacy score (PEscore) in predicting platelet transfusion efficacy in hematological patients. [Methods] A total of 485 patients with hematological diseases, including 298 males (62.09±15.45 years) and
LI Jun +4 more
doaj +1 more source
In 2016, the British Journal of Haematology platelet transfusion guideline suggests not giving prophylactic platelet transfusions to well ASCT patients with no bleeding [1].
Hickey, B +3 more
core +1 more source
ABSTRACT Heterozygous germline variants in CBL disrupt its function as a negative regulator of the Ras/MAPK pathway, classically predisposing to Juvenile myelomonocytic leukemia (JMML) and moyamoya. We describe two affected siblings carrying a paternally inherited CBL variant (c.1210 T> C, p.
Michal Bar‐Hakim +12 more
wiley +1 more source

